| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/16/2006 | WO2005114215A3 Method of improving t cell receptors |
| 03/16/2006 | WO2005112608A3 Modified plant transcription factors |
| 03/16/2006 | WO2005110457A3 Treatment of eating disorders and induction of lipolysis |
| 03/16/2006 | WO2005108995A3 Compositions, test kits and methods for detecting helicobacter pylori |
| 03/16/2006 | WO2005106488A3 Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2) |
| 03/16/2006 | WO2005103076A3 Erythropoietin protein variants |
| 03/16/2006 | WO2005100394A3 PURIFIED INTERLEUKIN-15/Fc FUSION PROTEIN AND PREPARATION THEREOF |
| 03/16/2006 | WO2005094891A3 Method for solubilising peptide mixtures |
| 03/16/2006 | WO2005084410A9 Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 03/16/2006 | WO2005084179A3 Improved method for preparing conjugates of proteins and chelating agents |
| 03/16/2006 | WO2005070468A3 Transglutaminase mediated conjugation of peptides |
| 03/16/2006 | WO2005070148A3 Methods of using high affinity atiii variants |
| 03/16/2006 | WO2005069852A3 Primary central nervous system tumor specific behab isoforms |
| 03/16/2006 | WO2005060998A3 Methods of modulating cytokine activity; related reagents |
| 03/16/2006 | WO2005021723A3 Nucleic acid molecules from rice controlling abiotic stress tolerance |
| 03/16/2006 | WO2005012337A3 Antigenic peptides of sars coronavirus and uses thereof |
| 03/16/2006 | WO2004099231A3 Glycopegylation methods and proteins/peptides produced by the methods |
| 03/16/2006 | WO2004038373A3 Apoptotic response regulation through interaction of tripartite motif protein 32 with pias |
| 03/16/2006 | WO2004033663A3 Carbohydrate-based synthetic vaccines for hiv |
| 03/16/2006 | WO2004031352A3 Interferon variants with improved properties |
| 03/16/2006 | WO2004024072A3 Novel compositions and methods for the treatment of immune related diseases |
| 03/16/2006 | WO2004019857A3 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
| 03/16/2006 | WO2004016733A3 Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| 03/16/2006 | WO2004000220A3 Methods for purifying viral particles for gene therapy |
| 03/16/2006 | WO2003077843A3 Methods for purifying selected cea family member proteins |
| 03/16/2006 | WO2003031586A3 Acrp30-like polynucleotides, polypeptides, and antibodies |
| 03/16/2006 | US20060059588 Production of transformed plants expressing thyroid stimulating hormone receptor |
| 03/16/2006 | US20060059583 Produced from Polypedilum vanderplanki larvae; introduction of these genes into animal cells successfully conferred desiccation resistance to the cells. |
| 03/16/2006 | US20060059578 Adiponectin-knoucout nonhuman animal |
| 03/16/2006 | US20060059577 Melusin a muscle specific protein, as a drug target for prevention and treatment of heart failure |
| 03/16/2006 | US20060058513 Oxime conjugates and methods for their formation and use |
| 03/16/2006 | US20060058512 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060058511 Method for stabilizing protein solution preparation |
| 03/16/2006 | US20060058510 Lipocalins having a cylindrical beta-pleated sheet of eight beta -strands connected pair-wise by four peptide loops to define a bindingpocket; sequences of bilin-binding protein of Pieris brassicae; genetic engineering; mutants; small chemical, peptide epitopes with determinable affinity >105 M-1 |
| 03/16/2006 | US20060058509 Refolding of membrane proteins |
| 03/16/2006 | US20060058508 Novel functional peptide nucleic acid and process for producing the same |
| 03/16/2006 | US20060058507 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders |
| 03/16/2006 | US20060058506 Synthetic anti-candida albicans oligosaccharide based vaccines |
| 03/16/2006 | US20060058505 Nucleic acid and polypeptide linked to breast cancer and uses therefor |
| 03/16/2006 | US20060058504 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases |
| 03/16/2006 | US20060058258 Gene transcription and ionizing radiation: methods and compositions |
| 03/16/2006 | US20060058253 Methods to reprogram splice site selection in pre-messenger rnas |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060058239 Use of the insulin-like-growth factor I isoform MGF for the treatment of neurological disorders |
| 03/16/2006 | US20060058237 p49/STRAP is a novel protein involved in gene regulation and cell proliferation |
| 03/16/2006 | US20060058235 Long lasting synthetic glucagon like peptide (GLP-1) |
| 03/16/2006 | US20060058234 VEGF traps and therapeutic uses thereof |
| 03/16/2006 | US20060058232 Methods of treating cancer using a modified endostatin protein |
| 03/16/2006 | US20060058231 Variants of human bone morphogenetic proteins and other cysteine knot cytokine proteins with improved properties, including increased expression yield, expression in absence of a pro-domain, increased solubility, increased specific activity, altered receptor, co-receptor, inhibitor specificity |
| 03/16/2006 | US20060058230 Analogs of parathyroid hormone and pth-related protein as bone anabolic agents |
| 03/16/2006 | US20060058228 nine amino acid, disulfide-constrained peptide that selectively bound and was internalized into colon cancer cells; exhibit decreased or a substantially nonexistent immunogenicity in an in vivo system |
| 03/16/2006 | US20060058227 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis |
| 03/16/2006 | US20060058226 Gd3-mimetic peptides |
| 03/16/2006 | US20060058221 Baclofen conjugate and a pharmaceutical composition for treatment of neuronal disorders |
| 03/16/2006 | US20060058189 Ftsz-polypeptides as a target for herbicidal compounds |
| 03/16/2006 | US20060057704 Composition |
| 03/16/2006 | US20060057700 Using glycosylated pilin as diagnostic indicator and preventative initation in treating pseudomonal infections; immunotherapy; glycosylated with the O-antigen; Pseudomonas aeruginosa; Escherichia coli |
| 03/16/2006 | US20060057694 Rat receptor tyrosine knase, kdr |
| 03/16/2006 | US20060057680 Mutant interleukin-15 polypeptides |
| 03/16/2006 | US20060057679 RAGE protein derivatives |
| 03/16/2006 | US20060057678 Chimeric proteins for diagnosis and treatment of diabetes |
| 03/16/2006 | US20060057677 Organic anion transporter and gene coding for the same |
| 03/16/2006 | US20060057676 which are induced by fermentable glucose or non-fermentable ethanol |
| 03/16/2006 | US20060057675 Human toll homologue |
| 03/16/2006 | US20060057673 Epitope analogs |
| 03/16/2006 | US20060057669 Inactive transcription factor tif-ia and uses thereof |
| 03/16/2006 | US20060057668 Antimicrobial polypeptide and utilization thereof |
| 03/16/2006 | US20060057667 Provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the transporter peptides, and methods of identifying modulators of the transporter peptides |
| 03/16/2006 | US20060057666 Human g protein coupled receptor |
| 03/16/2006 | US20060057665 Galectin-14 therapeutic molecule and uses thereof |
| 03/16/2006 | US20060057664 Polypeptides and polynucleotides encoding same |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057662 Membrane scaffold proteins |
| 03/16/2006 | US20060057649 Screening method and anti-tumor drug candidate obtained therefrom |
| 03/16/2006 | US20060057645 Novel genes |
| 03/16/2006 | US20060057641 Having T cell stimulatory activity of a dog dander allergen, therapy |
| 03/16/2006 | US20060057640 Using receptor tyrosine phosphatases as tools in identifying modulators for prevention and treatment of nervous system, cell proliferative and respiratory system disorders |
| 03/16/2006 | US20060057636 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/16/2006 | US20060057612 Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association |
| 03/16/2006 | US20060057607 Small RNAs and bacterial strains involved in quorum sensing |
| 03/16/2006 | US20060057602 related to testes-specific, vespid and pathogenic proteins (RTVP); metastatic prostatic neoplasia |
| 03/16/2006 | US20060057589 Identification and detection of algae species, strains and toxins |
| 03/16/2006 | US20060057582 83 human secreted proteins |
| 03/16/2006 | US20060057579 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 03/16/2006 | US20060057563 Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof |
| 03/16/2006 | US20060057179 Therapeutic polyesters and polyamides |
| 03/16/2006 | US20060057164 Isolated, purified polynucleotides, expression vector, host cells, antibodies; mutation functionally disrupting catalytic domain |
| 03/16/2006 | US20060057160 Vaccine composition |
| 03/16/2006 | US20060057158 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 03/16/2006 | US20060057156 Materials and methods for inductions of immune tolerance |
| 03/16/2006 | US20060057155 Adp-ribosylating bacterial toxins |
| 03/16/2006 | US20060057151 BmpB novel nucleotide and amino acid sequences and diagnostic and therapeutic uses thereof |
| 03/16/2006 | US20060057147 Antibody recognizing antibody |
| 03/16/2006 | US20060057141 Ovarian carcinoma polypeptides having a specific amino acid sequence, its fusion proteins and polynucleotides encoding them; cancer vaccines |
| 03/16/2006 | US20060057139 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060057135 Mucosal vascular addressins and uses thereof |
| 03/16/2006 | US20060057131 Malleable protein matrix and uses thereof |
| 03/16/2006 | US20060057130 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | US20060057116 Recombinant influenza viruses for vaccines and gene therapy |